Therapeutic Areas
Innovative drug delivery device solutions for a range of markets
We lead the way in the development of drug delivery device systems across various therapeutic fields. Our extensive knowledge covers multiple markets, each presenting distinct challenges and opportunities to enhance patient care and treatment results. With our specialization in inhalation, diagnostics, ocular, and parenteral markets, we collaborate with global pharmaceutical companies to design and produce high-quality drug delivery devices that patients can trust.
Inhalation
The inhalation market is centered on delivering medications via the respiratory system, primarily through inhalers, nebulizers, and nasal sprays to manage respiratory conditions like asthma and COPD, along with various systemic illnesses.
H&T Presspart is a leader in producing components for metered-dose inhalers, including cans, actuators, and dose counters, as well as dry powder inhalers. Our Global Technology Centre enables us to assist customers in the development and industrialization of their inhalation drug delivery devices.
Parenteral
Parenterals involve delivering drugs directly into the body through injection methods, such as IV, syringes, autoinjectors, or other injection devices.
Drug packaging encompasses ampoules, vials, prefilled syringes, cartridges, and more. Parenteral packaging typically contains small molecules, biologics, vaccines, biosimilars, and other substances.
H&T Presspart is equipped to assist customers in the development and industrialization of their parenteral drug delivery devices. In 2025, we will also introduce our Vytal Snap-Fit Container closure cap system designed for the parenteral vial market.
Ocular
As the aging population grows, the prevalence of ocular conditions like glaucoma, dry eye disease, macular degeneration, and diabetic retinopathy is on the rise, making the ocular drug delivery market a significant growth area within the pharmaceutical sector.
The emergence of implantable solid drugs, which enable the gradual release of medication over several months, has spurred increased investment in ocular drug delivery devices. H&T Presspart has collaborated with several companies in the specialized design and manufacture of ocular implanter drug delivery devices, positioning us well to assist other pharmaceutical companies aiming to introduce ocular devices to the market.
Diagnostics
The medical diagnostics market encompasses a diverse array of devices and technologies used to identify diseases or conditions in patients. This market is set for significant growth, fueled by technological advancements, a rising demand for early disease detection, and an increasing global need for healthcare services.
At H&T Presspart, we produce various devices for in-vitro diagnostic testing, including blood cards for blood group typing and antibody investigation, as well as a testing device for monitoring calprotectin levels in patients.
